編者:雷瑞鵬|責編:劉平|總主編:雷瑞鵬
雷瑞鵬，華中科技大學哲學繫系主任、生命倫理學研究中心執行主任，哲學博士，副教授。主要研究方向：生命科學哲學、生命倫理學；主要學術兼職：中國自然辯證法研究會理事暨生命倫理學專業委員會常務理事、亞洲生命倫理學會副會長(2010一2015)、哈佛大學「國際生物醫學和衛生研究倫理」項目研究員(2003—2005)、湖北省倫理學會常務理事、湖北省自然辯證法研究會常務理事等。在國內外期刊上發表中英文學術論文30余篇。譯著《勾勒姆醫生一一作為科學的醫學與作為救助手段的醫學》(上海世紀出版集團2009年版)。主持教育部人文社科青年項目「異種移植技術的倫理問題研究」；參與國家社科基金重大項目「高科技倫理問題研究」並作為子課題「合成生物學」負責人；主持與哈佛大學的國際合作研究項目「EthicalReview Of Research that Might，HarmNon—participants in China」；參加並負責協調組織2項中德和中美合作項目。
目錄
PART Ⅰ Ethical Debates on Synthetic Biology 1 An Analysis of the 「Playing God」 Argument against Synthetic Biology 1.1 Introduction 1.2 The Origin of 「Playing God」 Argument 1.3 The Interpretation of the Expression of Playing God 1.4 The Debate on Whether Synthetic Biology 「Plays God」 1.5 Deficiencies of 「Playing God」 as an Argument 1.6 References 2 Some Remarks on the Argument Appealing to Nature against Synthetic Biology 2.1 Introduction 2.2 The Argument Appealing to Nature against Synthetic Biology and an Analysis of Its Deficiencies 2.3 Ambiguity of the Concept Nature 2.4 Problems in the Morally Significant Line between the Natural and the Non/Unnatural 2.5 Allegations to Synthetic Biology Stemming from Argument Appealing to Nature 2.6 Conclusion 2.7 References 3 On the Biocentrist Argument against Synthetic Biology 3.1 Introduction 3.2 Biocentrism and Its Advocates: A Critique of Synthetic Biology 3.3 Argument Appealing to Natural Evolutionary History 3.4 Argument Appealing to Teleological Organization 3.5 Argument Appealing to the Good of Own or Interests 3.6 References 4 Research on Responsibility Ethics of DNA Synthesis Technology 4.1 Introduction 4.2 Ethics of Responsibility of Hans Jonas 4.3 The Necessity of Applying Ethics of Responsibility in DNA Synthesis Techniques 4.4 Application of Ethics of Responsibility in the Practice of DNA Synthesis Technology 4.5 Suggestions for Applying Ethics of Responsibility in the Practice of DNA Synthesis Technology 4.6 Conclusion 4.7 References 5 Analysis of Ethics Dumping and Proposed Solutions in the Field of Biomedical Research in China 5.1 Introduction 5.2 The Definition of Ethics Dumping 5.3 Typical Cases of Ethics Dumping in Biomedical Research in China 5.4 Analysis of the Causes of Ethics Dumping in Biomedical Research in China 5.5 Policy Recommendations 5.6 References PART Ⅱ Risk Analysis in Synthetic Biology 6 Safety Risks and Ethical Governance of Biomedical Applications of Synthetic Biology 6.1 Introduction 6.2 The Biomedical Applications of Synthetic Biology 6.3 An Analysis of the Safety Risks of the Application of Synthetic Biology within Biomedicine 6.4 Ethical Considerations in the Application of Synthetic Biology within the Biomedical Field 6.5 Recommendations for Ethical Governance of Biomedical Applications of Synthetic Biology 6.6 Conclusion
7.3 Challenges Faced by Existing Risk Governance Strategies 7.4 Governance Recommendations for Synthetic Virus Technology 7.5 Conclusion 7.6 References 8 Ethical Perspective on the Risk Assessment and Prospective Governance of Synthetic Biofuels 8.1 Introduction 8.2 Risk Assessment and Ethical Issues of Synthetic Biofuels 8.3 Prospective Governance of Synthetic Biofuels from an Ethical Perspective 8.4 Conclusion 8.5 References 9 Challenges and Principled Responses to Privacy Protection from Biometric Technology in China 9.1 Introduction 9.2 The Definition of Biometric Technology and Biometric Characteristics 9.3 The Challenges of Biometric Technology for Privacy Protection 9.4 Principled Responses to Privacy Protection from Biometric Technology 9.5 Conclusion 9.6 References PART Ⅲ Governance Countermeasures in Synthetic Biology 10 Ethical Framework on Risk Governance of Synthetic Biology 10.1 Introduction 10.2 The Relationship between Environmental Risk and Synthetic Biology 10.3 Methods for Environmental Risk Assessment of Synthetic Biology 10.4 Ethical Principles in Environmental Risk Governance 10.5 Conclusion 10.6 References 11 Establishing a Management Framework for Biosafety Risk Assessments of Synthetic Biology 11.1 Introduction 11.2 Synthetic Biology Enabling Technology 11.3 Biosafety Risk Assessments of Synthetic Biology 11.4 Framework for Biosafety Risk Assessments 11.5 Discussion 11.6 Summary 11.7 References 12 Risks and Countermeasures of Laboratory?Acquired Infection Based on Pathogen Transmission Routes 12.1 Introduction 12.2 LAI Risk Analysis Based on Transmission Routes 12.3 Response to LAIs with Different Transmission Routes 12.4 Comprehensive Strategy 12.5 Conclusion 12.6 References 13 Regulation and Management of the Biosecurity for Synthetic Biology 13.1 Introduction 13.2 Biosecurity Risks of Synthetic Biology 13.3 Situation of the Regulation and Management of Biosecurity for Synthetic Biology in the International Community 13.4 Situation of the Regulation and Management of Biosecurity for Synthetic Biology in China 13.5 Suggestions on the Regulation and Management of Biosecurity for Synthetic Biology in China 13.6 Conclusion 13.7 References 14 Can Synthetic Biological Products Be Applied 14.2 Progress in the Negotiation of Synthetic Biology under the Framework of the CBD 14.3 Application of Synthetic Biological Products under the Rules of the Biosafety Protocol 14.4 Conclusion 14.5 References 15 A Leap of Faith: Building the Trust in Human Biobanks 15.1 Introduction 15.2 Theoretical Foundations of Public Trust in HBs: A Leap of Faith 15.3 Is There a Universal Formula for the Construction of Public Trust in HBs? 15.4 Schemes for the Establishment and Reinforcement of Public Trust in HBs 15.5 Conclusion 15.6 References
[